CTNNBL1 and hepatocellular carcinoma: Hp-NAP recombined with the maltose binding protein of Escherichia coli(rMBP-NAP) stimulated TLR2-mediated Th-1-dependent anti-tumor immunity in hepatoma, sarcoma [220], and metastatic lung cancer [221].